Cargando…
Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study
We aimed to evaluate the safety and effectiveness of darunavir (DRV) in the treatment of human immunodeficiency virus-1 (HIV-1) infection in Korea. From October 29, 2010, 225 eligible patients with HIV-1 infection receiving DRV were enrolled. DRV was administered with other antiretroviral agents, an...
Autores principales: | Kim, Hyeongyeong, Kim, Youngdoe, Kang, Jiho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511379/ https://www.ncbi.nlm.nih.gov/pubmed/34405597 http://dx.doi.org/10.3947/ic.2020.0124 |
Ejemplares similares
-
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021) -
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection
por: Kim, Eun Jin, et al.
Publicado: (2020) -
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
por: Solana-Altabella, Antonio, et al.
Publicado: (2022) -
Human immunodeficiency virus infection and its association with sarcopenia
por: Pinto Neto, Lauro Ferreira da Silva, et al.
Publicado: (2015) -
Incidence and Seroprevalence of Hepatitis A Virus Infections among Young Korean Soldiers
por: Kang, Cheol-In, et al.
Publicado: (2007)